AlphaMark Advisors, LLC
- SEC CIK
- 0001348183
- Latest filing
- Jan 21, 2025
ALGS holding history
Aligos Therapeutics, Inc. in every 13F filed by AlphaMark Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALGS overviewAll 13F holders of ALGSFull Q4 2024 holdings
- Shares (Q4 2024)
- 1,100
- Value
- $44.0K
- % of portfolio
- <0.1%
- Quarters held
- 2
- Since Q3 2024